Click here to view this e-mail in a browser.
Conference Brief
OphthalmologyTimes.com

DAY 1 - Saturday, Nov. 10

Welcome

Ophthalmology Times welcomes ophthalmic professionals from around the world to Chicago. Our four-day coverage of this year’s meeting of the American Academy of Ophthalmology begins today and includes the latest research findings and clinical news of interest to readers.
Enjoy the meeting!


REFRACTIVE SUBSPECIALTY DAY

LASIK in patients with dry eye?

Patients with pre-existing dry eye can be candidates for LASIK if their condition is managed with appropriate preoperative, intraoperative, and postoperative techniques. » MORE

CXL effect on limbal stem cells studied

Preliminary results of a preclinical study investigating the effect of peripheral collagen crosslinking (CXL) on limbal stem cells provide some reassurance about the safety of the technique. » MORE

New WFG procedure promising

A new wavefront-guided (WFG) LASIK procedure provides superior cylinder correction, better uncorrected visual acuity outcomes, and slightly higher patient satisfaction. » MORE

Phakic IOL explantation effective

Results of a retrospective, observational, multicenter study including 140 eyes demonstrate the safety and efficacy of phakic IOL explantation surgery. » MORE


FROM THE SHOW FLOOR

Heidelberg MultiColor imaging approved

Heidelberg Engineering has received FDA clearance for its MultiColor scanning laser imaging as a new dimension in multi-modality fundus imaging with the Spectralis product family. » MORE

Quantel, Iridex sign global license deal

Quantel Medical and Iridex have signed a global patent licensing agreement that gives Quantel access to Iridex's MicroPulse technology. » MORE

Editor's Blog: Summit builds alliances for ophthalmic innovation

The Ophthalmology Innovation Summit provides a forum for the leaders of ophthalmology to look at all aspects of the innovation process to create additional innovation and to circumvent issues that hinder that innovation. » MORE


DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.

We welcome your feedback!
Please send your comments to:

Mark L. Dlugoss

Editor-in-Chief

Advanstar Eye Health Group

[email protected]